News Large study points to benefits - and risks - of GLP-1 drugs The largest observational study of GLP-1 weight-loss drugs suggests their benefits could be wide-ranging, but there are some risks to consider.
News Experts deplore Trump's order for US to exit from WHO One of the first acts of President Donald Trump after his inauguration yesterday was to order the start of the US's withdrawal from the WHO.
News CDC wants faster testing for bird flu in hospitals Hospitals should expand and speed up testing of people hospitalised with influenza to see if they are suffering from bird flu, says CDC.
News AI 'can spot cognitive decline linked to menopause' An AI can identify women who are at risk of experiencing a severe decline in cognitive function in menopause, which can be a risk factor for dementia.
News FDA bans red dye used in medicines over cancer risk The FDA has banned the use of a red dye used in oral medicines, foods and dietary supplements, more than 30 years after it was linked to cancer.
News Santhera preps UK Duchenne drug launch after NICE says yes Santhera will launch its new drug for Duchenne muscular dystrophy in the UK within the next few weeks after getting the green light for NHS coverage.
News Lilly partners with Hims & Hers on obesity drug sales Eli Lilly has signed an agreement with Hims & Hers that will see its weight-loss therapies sold directly on the telehealth company's platform.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.